Thu, Sep 15, 2022 page11

• Fosun shares and bonds plummet as scrutiny rises

  • Bloomberg
  • • 
    • 
    • 

  Investors are stepping up scrutiny of Fosun Group (復星集團), one of China’s largest private-sector conglomerates, as it faces as much as about US$8 billion in bond repayments through next year following signs of distress in credit markets.

  Some of Fosun’s US dollar bonds were yesterday on pace for record lows, extending declines following a drop on Tuesday that was the worst since a rout in June, when broader fears of contagion from a crisis in China’s property debt flared.

  Shares of Fosun International Ltd (復星國際), the group’s most-important arm, yesterday slid as much as 9.6 percent in Hong Kong to HK$4.41, the lowest level since November 2012.

  

  The logo of Chinese conglomerate Fosun Group is pictured on top of a building near a military slogan in Beijing on Dec. 12, 2015.

  Photo: AFP

  Authorities including banking watchdog China Banking and Insurance Regulatory Commission have told large lenders and state-owned enterprises to start a round of checks on their financial exposure to Fosun, people familiar with the matter said earlier this week.

  The group’s businesses span everything from Club Med to French fashion house Lanvin and the exclusive distributor of BioNTech SE’s COVID-19 vaccine in Greater China.

  The Beijing branch of the State-owned Assets Supervision and Administration Commission asked local state-owned enterprises for details about their links to Fosun that include stock holdings, debt lending and guarantees, the people said.

  Fosun said in a statement yesterday that the commission did not ask banks to check their financial exposure to Fosun, and the banks that worked with Fosun did not receive any notice about this after checking with regulators via “various channels.”

  The commission did not immediately respond to a Bloomberg request for comment.

  Moody’s Investors Service last month downgraded the conglomerate’s flagship operation further into junk territory for reasons including “elevated refinancing pressure” and risks related to plans to divest assets.

  Fosun entities earlier this month disclosed intentions to pare their stakes in the group’s publicly listed tourism and pharmaceutical units.

  Several Fosun group entities have been planning to pare stakes in other publicly held Fosun businesses.

  The tourism arm’s shares plunged a record 21 percent on Tuesday last week as Fosun International sold a 2 percent stake at a 15 percent discount to previous market prices.

  Stakes in a miner and a liquor company were also sold off in recent weeks while another entity plans to sell as much as 3 percent of Shanghai Fosun Pharmaceutical Group Co (上海復星醫藥集團).

  The moves have raised concerns about how Fosun would balance liquidity needs. Cash holdings at Fosun International were 117.7 billion yuan (US$16.9 billion) as of June 30, while total liabilities were 651 billion yuan, 40 percent of which was interest-bearing borrowings.

  Some offshore bonds guaranteed by the firm have dropped below US$0.45 on the dollar, well into what is considered distressed territory.

  Fosun International executive director Gong Ping (龔平) said Fosun’s recent share sale was aimed at optimizing its asset portfolio, and was not a response only to the current market environment, the statement said.
• Most Popular

  • 1

    HSR to encircle Taiwan

  • 2

    MOFA welcomes Rubio’s Taiwan remarks

  • 3

    China seeks to divide Okinawa: report

  • 4

    Two local airlines could be fined for hard landings

  • 5

    SPEAK UP: Let’s check your horoscope for 2025 (2/2) 2025年12星座運勢揭曉（下）